Nanobiotix S.A. (NBTX) vs Omeros (OMER)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Omeros (OMER) has outperformed Nanobiotix S.A. (NBTX) over the past year, gaining 322.3% versus a gain of 17.4%. Over five years, OMER leads with a +142.6% price change compared with +92.0% for NBTX. Omeros is the larger company by market cap ($1.36 billion vs $1.25 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NBTX | OMER |
|---|---|---|
| Share price | $24.62 | $18.75 |
| Market cap | $1.25B | $1.36B |
| 1-day change | -2.42% | +1.30% |
| YTD return | +6.49% | +9.14% |
| 1-year return | +17.41% | +322.30% |
| 5-year return | +92.04% | +142.56% |
| P/E ratio (TTM) | — | 15.37 |
| Forward P/E | — | 15.24 |
| EPS (TTM) | $-1.27 | $1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $57.14 | $21.24 |
| 52-week low | $14.78 | $4.06 |
| Distance from 52-week high | -56.91% | -11.72% |
| Average volume | 147.71K | 1.75M |
| Shares outstanding | 50.92M | 72.39M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OMER has outperformed NBTX by 304.9 percentage points over the past year.
NBTX vs OMER FAQ
Which is bigger, Nanobiotix S.A. or Omeros?
Omeros (OMER) is larger, with a market capitalization of $1.36B compared with $1.25B for Nanobiotix S.A. (NBTX).
Which stock has performed better over the past year, NBTX or OMER?
OMER returned +322.30% over the past 12 months, compared with +17.41% for NBTX (price return, excluding dividends). Past performance does not predict future results.
Are Nanobiotix S.A. and Omeros in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.